UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 111

Sortiert nach

Prednisolone and Mycobacterium indicus pranii in Tuberculous Pericarditis

The New England journal of medicine, 2014-09, Vol.371 (12), p.1121-1130

2014

Volltextzugriff (PDF)

Tuberculosis and human immunodeficiency virus co-infections and their predictors at a hospital-based HIV/AIDS clinic in Uganda

The international journal of tuberculosis and lung disease, 2010-12, Vol.14 (12), p.1621

2010

Volltextzugriff (PDF)

Severity of Human Immunodeficiency Virus Infection Is Associated with Decreased Phase Angle, Fat Mass and Body Cell Mass in Adults with Pulmonary Tuberculosis Infection in Uganda

The Journal of nutrition, 2001-11, Vol.131 (11), p.2843-2847

2001

Volltextzugriff (PDF)

Pregnancy and infant outcomes among HIV-infected women taking long-term ART with and without tenofovir in the DART trial

PLoS medicine, 2012-05, Vol.9 (5), p.e1001217

2012

Volltextzugriff (PDF)

Mortality in the Year Following Antiretroviral Therapy Initiation in HIV-Infected Adults and Children in Uganda and Zimbabwe

Clinical infectious diseases, 2012-12, Vol.55 (12), p.1707-1718

2012

Volltextzugriff (PDF)

Interventions for Maintenance of Essential Health Service Delivery during the COVID-19 Response in Uganda, between March 2020 and April 2021

International journal of environmental research and public health, 2022-09, Vol.19 (19), p.12522

2022

Volltextzugriff (PDF)

Low risk of death, but substantial program attrition, in pediatric HIV treatment cohorts in Sub-Saharan Africa

Journal of acquired immune deficiency syndromes (1999), 2008-12, Vol.49 (5), p.523

KIDS-ART-LINC Collaboration

2008

Volltextzugriff (PDF)

Private sector engagement in the COVID-19 response: experiences and lessons from the Democratic Republic of Congo, Nigeria, Senegal and Uganda

Globalization and health, 2022-06, Vol.18 (1), p.60-60, Article 60

2022

Volltextzugriff (PDF)

RAPID-VL intervention improves viral load ordering, results turnaround time and viral suppression: a cluster randomized trial in HIV clinics in Uganda

Journal of the International AIDS Society, 2021-07, Vol.24 (S4), p.74

2021

Volltextzugriff (PDF)

Cost effectiveness analysis of clinically driven versus routine laboratory monitoring of antiretroviral therapy in Uganda and Zimbabwe

PloS one, 2012-04, Vol.7 (4), p.e33672

2012

Volltextzugriff (PDF)

High level of viral suppression and low switch rate to second-line antiretroviral therapy among HIV-infected adult patients followed over five years: retrospective analysis of the DART trial

PloS one, 2014-03, Vol.9 (3), p.e90772

2014

Volltextzugriff (PDF)

Clinical differences between younger and older adults with HIV/AIDS starting antiretroviral therapy in Uganda and Zimbabwe: a secondary analysis of the DART trial

PloS one, 2013-10, Vol.8 (10), p.e76158-e76158

2013

Volltextzugriff (PDF)

Quantitative sputum bacillary load during rifampin-containing short course chemotherapy in human immunodeficiency virus-infected and non-infected adults with pulmonary tuberculosis

The international journal of tuberculosis and lung disease, 2000-06, Vol.4 (6), p.528

2000

Volltextzugriff (PDF)

Patterns of individual and population-level adherence to antiretroviral therapy and risk factors for poor adherence in the first year of the DART trial in Uganda and Zimbabwe

Journal of acquired immune deficiency syndromes (1999), 2008-08, Vol.48 (4), p.468

2008

Volltextzugriff (PDF)

Evolution of drug resistance during 48 weeks of zidovudine/lamivudine/tenofovir in the absence of real-time viral load monitoring

Journal of acquired immune deficiency syndromes (1999), 2010-10, Vol.55 (2), p.277

2010

Volltextzugriff (PDF)

The impact of first year adherence to antiretroviral therapy on long‐term clinical and immunological outcomes in the DART trial in Uganda and Zimbabwe

Tropical medicine & international health, 2012-05, Vol.17 (5), p.584-594

2012

Volltextzugriff (PDF)

Dynamic logistic regression model and population attributable fraction to investigate the association between adherence, missed visits and mortality: a study of HIV-infected adults surviving the first year of ART

BMC infectious diseases, 2013-08, Vol.13 (1), p.395-395, Article 395

2013

Volltextzugriff (PDF)

Lopinavir/Ritonavir Monotherapy after 24 Weeks of Second-Line Antiretroviral Therapy in Africa: A Randomized Controlled Trial (Sara)

Antiviral therapy, 2012-01, Vol.17 (7), p.1363-1373

2012

Volltextzugriff (PDF)

A single CD4 test with 250 cells/mm3 threshold predicts viral suppression in HIV-infected adults failing first-line therapy by clinical criteria

PloS one, 2013, Vol.8 (2), p.e57580-e57580

2013

Volltextzugriff (PDF)

Residual Activity of Two HIV Antiretroviral Regimens Prescribed without Virological Monitoring

Antimicrobial Agents and Chemotherapy, 2011-10, Vol.55 (10), p.4575-4580

2011

Volltextzugriff (PDF)

Quantitative bacillary response to treatment in Mycobacterium tuberculosis infected and M. africanum infected adults with pulmonary tuberculosis

The international journal of tuberculosis and lung disease, 2001-06, Vol.5 (6), p.579

2001

Volltextzugriff (PDF)

Drug Tolerance in Mycobacterium tuberculosis

Antimicrobial Agents and Chemotherapy, 1999-11, Vol.43 (11), p.2600-2606

1999

Volltextzugriff (PDF)

Acceptability of routine HIV counselling and testing, and HIV seroprevaience in Ugandan hospitals

Bulletin of the World Health Organization, 2008-04, Vol.86 (4), p.241-320

2008

Volltextzugriff (PDF)

Induction of the Antigen 85 Complex of Mycobacterium tuberculosis in Sputum: A Determinant of Outcome in Pulmonary Tuberculosis Treatment

The Journal of infectious diseases, 1998-10, Vol.178 (4), p.1115-1121

1998

Volltextzugriff (PDF)

Predicting the outcome of therapy for pulmonary tuberculosis

American journal of respiratory and critical care medicine, 2000-04, Vol.161 (4), p.1076-1080

2000

Volltextzugriff (PDF)

1 – 25 von 111

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(106)
Mit Volltextzugriff
(101)

Publikationsform

Artikel
(111)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(78)
Life Sciences & Biomedicine
(73)
Humans
(62)
Hiv
(45)
Female
(41)
Human Immunodeficiency Virus
(40)
Adult
(39)
Infectious Diseases
(39)
Uganda
(33)
Hiv Infections - Drug Therapy
(32)
Male
(31)
Uganda - Epidemiology
(27)
Public, Environmental & Occupational Health
(21)
Antiretroviral Therapy
(20)
Biological And Medical Sciences
(20)
Drug Therapy
(20)
Medical Sciences
(20)
Anti-Hiv Agents - Therapeutic Use
(19)
Adolescent
(18)
Aids
(17)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Prednisolone and Mycobacterium indicus pranii in Tuberculous Pericarditis

Tuberculosis and human immunodeficiency virus co-infections and their predictors at a hospital-based HIV/AIDS clinic in Uganda

Severity of Human Immunodeficiency Virus Infection Is Associated with Decreased Phase Angle, Fat Mass and Body Cell Mass in Adults with Pulmonary Tuberculosis Infection in Uganda

Pregnancy and infant outcomes among HIV-infected women taking long-term ART with and without tenofovir in the DART trial

Mortality in the Year Following Antiretroviral Therapy Initiation in HIV-Infected Adults and Children in Uganda and Zimbabwe

Interventions for Maintenance of Essential Health Service Delivery during the COVID-19 Response in Uganda, between March 2020 and April 2021

Low risk of death, but substantial program attrition, in pediatric HIV treatment cohorts in Sub-Saharan Africa

Private sector engagement in the COVID-19 response: experiences and lessons from the Democratic Republic of Congo, Nigeria, Senegal and Uganda

RAPID-VL intervention improves viral load ordering, results turnaround time and viral suppression: a cluster randomized trial in HIV clinics in Uganda

Cost effectiveness analysis of clinically driven versus routine laboratory monitoring of antiretroviral therapy in Uganda and Zimbabwe

High level of viral suppression and low switch rate to second-line antiretroviral therapy among HIV-infected adult patients followed over five years: retrospective analysis of the DART trial

Clinical differences between younger and older adults with HIV/AIDS starting antiretroviral therapy in Uganda and Zimbabwe: a secondary analysis of the DART trial

Quantitative sputum bacillary load during rifampin-containing short course chemotherapy in human immunodeficiency virus-infected and non-infected adults with pulmonary tuberculosis

Patterns of individual and population-level adherence to antiretroviral therapy and risk factors for poor adherence in the first year of the DART trial in Uganda and Zimbabwe

Evolution of drug resistance during 48 weeks of zidovudine/lamivudine/tenofovir in the absence of real-time viral load monitoring

The impact of first year adherence to antiretroviral therapy on long‐term clinical and immunological outcomes in the DART trial in Uganda and Zimbabwe

Dynamic logistic regression model and population attributable fraction to investigate the association between adherence, missed visits and mortality: a study of HIV-infected adults surviving the first year of ART

Lopinavir/Ritonavir Monotherapy after 24 Weeks of Second-Line Antiretroviral Therapy in Africa: A Randomized Controlled Trial (Sara)

A single CD4 test with 250 cells/mm3 threshold predicts viral suppression in HIV-infected adults failing first-line therapy by clinical criteria

Residual Activity of Two HIV Antiretroviral Regimens Prescribed without Virological Monitoring

Quantitative bacillary response to treatment in Mycobacterium tuberculosis infected and M. africanum infected adults with pulmonary tuberculosis

Drug Tolerance in Mycobacterium tuberculosis

Acceptability of routine HIV counselling and testing, and HIV seroprevaience in Ugandan hospitals

Induction of the Antigen 85 Complex of Mycobacterium tuberculosis in Sputum: A Determinant of Outcome in Pulmonary Tuberculosis Treatment

Predicting the outcome of therapy for pulmonary tuberculosis

Suchergebnisse filtern